General discussion, page-10989

DF, or anyone for that matter,
I'm wondering what your thoughts are on how IHL will be valued on the Nasdaq when we list.

I'm not sure what is happening in the US in regards to the shroom/cannabis stocks, but they have all been falling the last year, and the m/caps have halved, from what they were. Have you or anyone got a handle on what is happening in this space.

Looks like IHL will be coming onstream to a downwards market in this space. I'm tempering my SP targets to approx $1-$1.20 as a peer valuation, at some time after listing.

I know good results mean m/cap $$ to these stocks and vice versa, so ultimately our SP will be judged on this, which if sleep apnea results are positive, then I believe a SP of >$2 beckons.